表紙
市場調查報告書

無針裝置:技術及全球市場

Needle-Free Devices: Technologies and Global Markets

出版商 BCC Research 商品編碼 321389
出版日期 內容資訊 英文 170 Pages
訂單完成後即時交付
價格
無針裝置:技術及全球市場 Needle-Free Devices: Technologies and Global Markets
出版日期: 2019年03月22日內容資訊: 英文 170 Pages
簡介

世界無針裝置市場規模在2018年達到30億美元,預計在2023年將會成長至46億美元,擁有9.3%的CAGR (複合年均增長率) 。

本報告調查世界無針裝置市場,統整了全球市場與相關技術概要、市場動態分析預測、地區別分析、市場影響要素及市場機會分析、無針藥物輸遞裝置分析、市場策略、競爭情勢、法規結構及價格、醫療費償付相關討論,以及主要企業檔案等。

第1章 簡介

第2章 摘要和重點提要

第3章 市場概要

第3章 藥物輸遞裝置

  • 人類皮膚構造:表皮、真皮、皮下組織
  • 藥物輸遞裝置、技術概要
  • 無針裝置
  • 藥物輸遞:技術別
    • 緩釋型藥物輸遞
    • 前體藥物
    • 置入物、子宮內避孕用具(ITD)
    • 標的型藥物輸遞
    • 聚合物藥物輸遞
  • 藥物輸遞裝置:投藥途徑別
    • 經口藥物輸遞
    • 注射/非經口藥物輸遞
    • 經肺藥物輸遞
    • 經鼻藥物輸遞
    • 口腔黏膜藥物輸遞
    • 直腸藥物輸遞
    • 眼部藥物輸遞
    • 經皮藥物輸遞
  • 藥物輸遞手法有進一步改良的必要性
    • 現在進行中的研究領域

第4章 無針技術與藥物輸遞裝置

  • 無針、藥物輸遞裝置與其種類
  • 無針裝置歷史
  • 無針裝置需求
  • 無針技術優點

第5章 無針裝置市場動態

  • 市場促進要素
    • 針扎意外增加
    • 針頭恐懼症案件數增加
    • 無痛藥物輸遞需求增加
    • 產品開發
    • 全球各國糖尿病患者增加
    • 全球各國血液傳染病的發病數增加
    • HIV/AIDS患者增加
  • 市場抑制要素
    • 相對高價的無針技術
    • 替代性藥劑輸遞方法的易用性
    • 高額的研究開發(R&D)投資
    • 市場競爭
    • 產品生命週期之短
  • 競爭環境

第6章 產品種類別的市場區分

  • 簡介
  • 無針注射器
    • 簡介
    • 歷史背景
    • 臨床上需求
    • 零件
    • 作用機制(MoA)
    • 應用
    • unmet needs
    • 未來市場動態
    • 無針注射器市場:地區別
  • 無針注射器市場:種類別
    • 治療領域別
    • 藥物輸遞別
    • 動力源別
    • 使用方法種類別
  • 抽吸器技術
    • 經肺藥物輸遞
    • 抽吸器優點與缺點
    • 經肺藥物輸遞的進步
    • 進一步開發
    • 經肺藥物輸遞市場:地區別
  • 抽吸器種類
    • 定量噴霧式吸引器 (MDI)
    • 乾粉吸引器
  • 經皮貼片技術
    • 經皮藥物輸遞
    • 臨床需求
    • 過去背景情況
    • 經皮貼片種類
    • 零件
    • 相對於其他投藥方式,經皮貼片的優點
    • 經皮貼片的最新技術創新
    • 經皮貼片的臨床上問題點
    • 今後市場趨勢
    • 經皮貼片技術市場:地區別
  • 其他新型技術
    • 微針
    • 筆形針

第7章 用途別的市場區分

  • 無針裝置的用途
    • 疼痛管理
    • 疫苗接種
    • 胰島素投藥
    • 小兒用藥輸遞

第8章 地區別的市場區分

  • 簡介
  • 北美 (美國、加拿大、墨西哥)
  • 歐洲 (德國、法國、英國、義大利、西班牙)
  • 亞太地區 (中國、印度、日本、韓國等)
  • 南美洲
  • 中東及非洲

第9章 市場策略

  • 市場策略
  • 企業合併、收購(M&A):主要動態
  • 在宅治療的擴大趨勢
  • 產品□技術開發:主要動態

第10章 已上市/研發產品

  • 主要的已上市產品
    • 無針注射器
    • 抽吸器
    • 經皮貼片
    • 其他新型用針技術
  • 研發產品
    • 無針注射器
    • 定量噴霧式吸引器 (MDI)
    • 經皮貼片

第11章 法規結構

  • 各地區/主要國家的法規結構
  • FDA (美國食藥署) 提出的技術性問題
    • FDA的呼籲與安全警告資訊
  • 勞動衛生、安全法

第12章 醫療費償付與價格水準

  • 各地區醫療費償付結構
  • 價格動向

第13章 無針裝置市場:結論與未來展望

  • 市場主要影響因素
    • 社會性因素
    • 技術開發
    • 人口經濟動態
    • 醫療產業結構轉型
    • 未來展望

第14章 公司檔案

  • 3M
  • ACTIVA BRAND PRODUCTS, INC.
  • AKRA DERMOJET
  • ALKERMES PLC
  • AMNIO TECHNOLOGY LLC.
  • ANTARES PHARMA, INC.
  • ARADIGM CORP.
  • 安斯泰來製藥
  • ASTRAZENECA PLC
  • BATTELLE
  • BESPAK EUROPE LTD.
  • BIOJECT MEDICAL TECHNOLOGIES
  • BRISTOL-MYERS SQUIBB
  • CLEARSIDE BIOMEDICAL, INC.
  • CORIUM INTERNATIONAL, INC.
  • CROSSJECT
  • CAPTISOL
  • D'ANTONIO CONSULTANTS INTERNATIONAL
  • DUOJECT MEDICAL SYSTEMS, INC.
  • DURECT CORP.
  • ECHO THERAPEUTICS
  • ENDO INTERNATIONAL
  • FERNDALE PHARMA GROUP, INC.
  • FERRING PHARMACEUTICALS, INC.
  • GERRESHEIMER AG
  • GLAXOSMITHKLINE PLC
  • GLIDE PHARMACEUTICAL TECHNOLOGIES LTD.
  • HASELMEIER GMBH
  • INJEX PHARMA AG
  • JCR Pharmaceuticals
  • KEYSTONE INDUSTRIES
  • LINEAGE THERAPEUTICS, INC.
  • LOHMANN THERAPIE-SYSTEME AG
  • MEDICAL INTERNATIONAL TECHNOLOGIES
  • MEDTRONIC
  • MERCK SERONO S.A.
  • MINNESOTA RUBBER & PLASTICS
  • MYLAN, INC.
  • NANOPASS TECHNOLOGIES LTD.
  • NATIONAL MEDICAL PRODUCTS, INC.
  • NOVARTIS
  • NOVEN PHARMACEUTICALS
  • NOVO NORDISK A/S
  • NYPRO, INC.
  • PENJET CORP.
  • SYNERON MEDICAL LTD.
  • TEAM CONSULTING LTD.
  • TEVA PHARMACEUTICALS INDUSTRIES LTD.
  • THERAJECT, INC.
  • VALERITAS, INC.
  • VAXXAS PTY LTD.
  • YPSOMED AG
  • ZOGENIX, INC.

第15章 附錄:簡稱一覽

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: HLC178B

Report Highlights:

The global market for needle-free devices should grow from $3.0 billion in 2018 to $4.6 billion by 2023, increasing at a compound annual growth rate (CAGR) of 9.3% from 2018 to 2023.

The global market for inhaler technologies should grow from $1.7 billion in 2018 to $2.1 billion by 2023, increasing at a CAGR of 4.5% from 2018 to 2023.

The global market for transdermal patch technologies should grow from $378.9 million in 2018 to $1.0 billion by 2023, increasing at a CAGR of 21.7% from 2018 to 2023.

Report Scope:

This report provides a detailed description of needle-free devices and the latest technologies in the market. The report includes market estimates for different types of needle-free devices. The report also includes recent technological developments and assessments of product performance in the market.

Based on the product type, the global needle-free device market is segmented into Needle-free Injectors, Inhaler technologies, Transdermal patch technologies and Other novel technologies (e.g., microneedles and pen needles).

Based on the application, the global needle-free device market is segmented into Pain management, Vaccine delivery, Insulin delivery and Pediatric drug delivery.

The report includes a list of marketed and pipeline products available in the market. The report discusses the qualitative and quantitative factors influencing market growth. The market drivers, restraints and opportunities are discussed in the report.

This report discusses some of the major drivers and restraints in the global needle-free device market, as well as the competition in the global needle-free device market and the key players' strategies and performances. The discussion is focused on the major market players, trends in product launches, collaborations, and mergers and acquisitions. The report also emphasizes on the company profiles of major vendors including company overview, key product offerings, financial statistics, and other developments. The report also provides insights on the market share and upcoming regional demand for the needle-less technologies.

Some of the major market players discussed in the report are 3M, Antares Pharma AG, Medtronic, Novartis and Teva Pharmaceuticals. For market estimates, data has been provided for the year 2017 as the base year, with forecasts for 2018 through 2023. Estimated values used are based on manufacturers' total revenues. Projected and forecasted revenue values are in constant U.S. dollars, unadjusted for inflation.

Report Includes:

  • 36 data tables and 34 additional tables
  • Detailed overview of the global markets for needle-free devices and technologies within the industry
  • Analyses of global market trends with data from 2017 and 2018, and projections of compound annual growth rates (CAGRs) through 2023
  • Country specific data and analysis for United States, Canada, Mexico, France, Germany, U.K., Spain, China, India, Japan, South Korea, Middle East and Africa
  • Assessment of the recent developments, key technological updates and product performance within the needle-free devices market
  • Insight into various needle-free technologies that are used in drug delivery and their various application areas
  • A look at the government regulations that can affect the global needle-free devices market
  • Identification of the competitive landscape of the market with the leading market players, suppliers and pharmaceutical partners
  • Profiles of major vendor companies, including 3M, AstraZeneca PLC, Bristol-Myers Squibb, GlaxoSmithKline PLC (GSK), Medtronic, Merck Serono S.A., and Teva Pharmaceutical Industries Ltd.

Table of Contents

Chapter 1: Introduction

  • Study Background
  • Study Goals and Objectives
  • Reasons for Doing This Study
  • Scope of Report
  • Information Sources
  • Methodology
  • Geographic Breakdown
  • Analyst's Credentials
  • BCC Custom Research
  • Related BCC Research Reports

Chapter 2: Summary and Highlights

Chapter 3: Drug Delivery Devices Structure of Human Skin

  • Epidermis
  • Dermis
  • Hypodermis
  • Overview of Drug Delivery Systems and Technologies
  • Needle-free Devices
  • Drug Delivery, by Technology
    • Sustained Release Drug Delivery
    • Prodrug
    • Implants and Intrauterine Devices
    • Targeted Drug Delivery
    • Polymeric Drug Delivery
  • Drug Delivery Systems, by Route of Administration
    • Oral Drug Delivery
    • Injectable or Parental Drug Delivery
    • Pulmonary Drug Delivery
    • Nasal Drug Delivery
    • Oral Mucosal Drug Delivery
    • Rectal Drug Delivery
    • Ocular Drug Delivery
    • Transdermal Drug Delivery
  • Need for Better Methods of Drug Delivery
    • Areas of Ongoing Research

Chapter 4: Needle-free Technology and Drug Delivery Devices

  • Needle-free Drug Delivery Devices and Types
  • History of Needle-free Devices
  • Demand for Needle-free Devices
  • Advantages of Needle-free Technology

Chapter 5: Needle-free Device Market Dynamics

  • Market Drivers
    • Increasing Incidence of Needlestick Injuries
    • Growing Cases of Needle Phobia
    • Increasing Demand for Painless Drug Delivery
    • Product Innovations
    • Increased Prevalence of Diabetes Globally
    • Increasing Incidence of Blood-Borne Diseases Globally
    • Growing Cases of HIV/AIDS
  • Market Restraints
    • Comparative High Cost of Needle-free Technology
    • Alternatives Available for Drug Delivery
    • High R&D Investments
    • Market Competition
    • Short Product Life Cycle
  • Competitive Landscape

Chapter 6: Market Breakdown by Product Type

  • Introduction
  • Needle-free Injectors
    • Introduction
    • Historical Background
    • Clinical Need
    • Components
    • Mechanism of Action
    • Applications
    • Unmet Needs
    • Future Developments
    • Needle-free Injectors Market, by Region
  • Needle-free Injectors Types
    • Needle-free Injectors, by Medication
    • Needle-free Injectors, by Drug Delivery
    • Needle-free Injectors, by Source of Power
    • Needle-free Injectors, by Usage Type
  • Inhaler Technologies
    • Pulmonary Drug Delivery
    • Advantages and Disadvantages of Inhaler Technologies
    • Advances in Pulmonary Drug Delivery
    • Future Developments
    • Inhaler Technologies Market, by Region
  • Type of Inhalers
    • Metered Dose Inhalers
    • Dry Powder Inhalers
  • Transdermal Patch Technologies
    • Transdermal Drug Delivery
    • Clinical Need
    • Historical Background
    • Types of Transdermal Patches
    • Components
    • Benefits of Transdermal Patches Over Other Dosage Forms
    • New Innovations in Transdermal Patches
    • Clinical Issues of Transdermal Delivery
    • Future Developments
    • Transdermal Patch Technologies Market, by Region
  • Other Novel Technologies
    • Microneedles
    • Pen Needles

Chapter 7: Market Breakdown by Application

  • Application of Needle-free Devices
    • Pain Management
    • Vaccine Delivery
    • Insulin Delivery
    • Pediatric Drug Delivery

Chapter 8: Market Breakdown by Region

  • Introduction
  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • Germany
    • United Kingdom
    • France
    • Italy
    • Spain
  • Asia-Pacific
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • South America
  • Middle East and Africa

Chapter 9: Market Strategy

  • Market Strategy
  • Key Mergers and Acquisitions
    • Exclusive Partnership Announced by PharmaJet and Mundipharma
    • Aequus and Corium Jointly Collaborate for Transdermal Patches
    • United Therapeutics Corp. Entered into Licensing Agreement
    • Takeda Pharmaceutical Company and Portal Instruments Entered into Collaboration
    • Medherant Signed an Agreement with a Japanese Company
    • 3M Drug Delivery System Announced Collaboration with Panacea Pharmaceutical
    • Cipla and MannKind Corp. Entered into Collaboration
  • Increasing Adoption of Home Healthcare Concept
  • Key Product and Technology Developments
    • Hind Syringes Developed Disposable Pen Needle
    • BD Introduced New Pen Needle
    • Development of Innovative Transdermal Patch Technology
    • Introduction of Smart Inhalers
    • Vaxxas' Nanopatch Garners WHO Support for Polio Vaccine Delivery

Chapter 10: Marketed and Pipeline Products

  • Key Marketed Products
    • Needle-free Injectors
    • Inhalers
    • Transdermal Patch
    • Other Novel Needle Technologies
  • Pipeline Products
    • Needle-free Injectors
    • Metered Dose Inhalers
    • Transdermal Patches

Chapter 11: Regulatory Structure

  • Regional Regulatory Structures
    • United States
    • European Union
    • Japan
    • China
    • Hong Kong
    • Korea
    • Taiwan
    • India
  • FDA Technical Considerations
    • FDA Recall and Safety Alerts
  • Occupational Health and Safety Laws

Chapter 12: Reimbursement and Pricing

  • Regional Reimbursement Structure
    • United States
    • Europe
    • Japan
    • Rest of Asia-Pacific
  • Pricing Trends

Chapter 13: Conclusions and Outlook for Needle-free Devices

  • Major Market Influencers
    • Social Factors
    • Technological Developments
    • Demographic and Economic Trends
    • Transformations in the Healthcare Industry
    • Future Outlook

Chapter 14: Company Profiles

  • 3M
  • ACTIVA BRAND PRODUCTS, INC.
  • AKRA DERMOJET
  • ALKERMES PLC
  • AMNIO TECHNOLOGY LLC.
  • ANTARES PHARMA, INC.
  • ARADIGM CORP.
  • ASTELLAS PHARMA, INC.
  • ASTRAZENECA PLC
  • BATTELLE
  • BESPAK EUROPE LTD.
  • BIOJECT MEDICAL TECHNOLOGIES
  • BRISTOL-MYERS SQUIBB
  • CLEARSIDE BIOMEDICAL, INC.
  • CORIUM INTERNATIONAL, INC.
  • CROSSJECT
  • CAPTISOL
  • D'ANTONIO CONSULTANTS INTERNATIONAL
  • DUOJECT MEDICAL SYSTEMS, INC.
  • DURECT CORP.
  • ECHO THERAPEUTICS
  • ENDO INTERNATIONAL
  • FERNDALE PHARMA GROUP, INC.
  • FERRING PHARMACEUTICALS, INC.
  • GERRESHEIMER AG
  • GLAXOSMITHKLINE PLC
  • GLIDE PHARMACEUTICAL TECHNOLOGIES LTD.
  • HASELMEIER GMBH
  • INJEX PHARMA AG
  • JCR PHARMACEUTICALS CO. LTD.
  • KEYSTONE INDUSTRIES
  • LINEAGE THERAPEUTICS, INC.
  • LOHMANN THERAPIE-SYSTEME AG
  • MEDICAL INTERNATIONAL TECHNOLOGIES
  • MEDTRONIC
  • MERCK SERONO S.A.
  • MINNESOTA RUBBER & PLASTICS
  • MYLAN, INC.
  • NANOPASS TECHNOLOGIES LTD.
  • NATIONAL MEDICAL PRODUCTS, INC.
  • NOVARTIS
  • NOVEN PHARMACEUTICALS
  • NOVO NORDISK A/S
  • NYPRO, INC.
  • PENJET CORP.
  • SYNERON MEDICAL LTD.
  • TEAM CONSULTING LTD.
  • TEVA PHARMACEUTICALS INDUSTRIES LTD.
  • THERAJECT, INC.
  • VALERITAS, INC.
  • VAXXAS PTY LTD.
  • YPSOMED AG
  • ZOGENIX, INC.

Chapter 15: Appendix: List of Abbreviations

List of Tables

  • Summary Table: Global Market for Needle-free Devices, by Product Type, Through 2023
    • Table 1: Prodrugs and their Active Metabolites
    • Table 2: Advantages and Disadvantages of Oral Drug Delivery
    • Table 3: Advantages and Disadvantages of Injectable Drug Delivery
    • Table 4: Advantages and Disadvantages of Pulmonary Drug Delivery
    • Table 5: Advantages and Disadvantages of Nasal Drug Delivery
    • Table 6: Advantages and Disadvantages of Oral Mucosal Drug Delivery
    • Table 7: Advantages and Disadvantages of Rectal Drug Delivery
    • Table 8: Advantages and Disadvantages of Ocular Drug Delivery
    • Table 9: Advantages and Disadvantages of Transdermal Drug Delivery
    • Table 10: Global HIV-Infected People and New Cases, by Region, 2016
    • Table 11: Global Needle-free Device Market Vendors, by Ranking, 2017
    • Table 12: Global Market for Needle-free Devices, by Product Type, Through 2023
    • Table 13: Advantages and Disadvantages of Needle-free Injectors
    • Table 14: Global Market for Needle-free Injectors, by Region, Through 2023
    • Table 15: Global Market for Needle-free Injectors, by Medication, Through 2023
    • Table 16: Global Market for Needle-free Injectors, by Drug Delivery, Through 2023
    • Table 17: Ideal Characteristics of Therapeutic Aerosols
    • Table 18: Advantages and Disadvantages of Pulmonary Drug Delivery
    • Table 19: Advantages and Disadvantages of Inhaler Technologies
    • Table 20: Asthma Prevalence, by Country, 2016-2018
    • Table 21: Global Market for Inhaler Technologies, by Region, Through 2023
    • Table 22: Advantages and Disadvantages of Metered Dose Inhalers
    • Table 23: Advantages and Disadvantages of Standard Press and Breath MDIs
    • Table 24: Advantages and Disadvantages of Dry Powder Inhalers
    • Table 25: Global Market for Inhaler Technologies, by Type, Through 2023
    • Table 26: Ideal Properties of Transdermal Drug Delivery Systems
    • Table 27: Parameters Affecting Selection of Drugs in Transdermal Drug Delivery Systems
    • Table 28: Advantages and Disadvantages of Transdermal Patches
    • Table 29: Global Market for Transdermal Patch Technologies, by Region, Through 2023
    • Table 30: Global Market for Other Novel Technologies, by Region, Through 2023
    • Table 31: Advantages and Disadvantages of Microneedle Technologies
    • Table 32: Advantages and Disadvantages of Pen Needles
    • Table 33: Top 10 Countries with High Percentage of Diabetic Population, 2017
    • Table 34: Comparison Between Painful and Painless Needle-free Insulin Drug Delivery Systems
    • Table 35: Global Market for Needle-free Devices, by Region, Through 2023
    • Table 36: United States Market for Needle-free Devices, by Product Segment, Through 2023
    • Table 37: Canadian Market for Needle-free Devices, by Product Segment, Through 2023
    • Table 38: Mexican Market for Needle-free Devices, by Product Segment, Through 2023
    • Table 39: European Market for Needle-free Devices, by Product Segment, Through 2023
    • Table 40: German Market for Needle-free Devices, by Product Segment, Through 2023
    • Table 41: U.K. Market for Needle-free Devices, by Product Segment, Through 2023
    • Table 42: French Market for Needle-free Devices, by Product Segment, Through 2023
    • Table 43: Italian Market for Needle-free Devices, by Product Segment, Through 2023
    • Table 44: Spanish Market for Needle-free Devices, by Product Segment, Through 2023
    • Table 45: Asia-Pacific Market for Needle-free Devices, by Product Segment, Through 2023
    • Table 46: Chinese Market for Needle-free Devices, by Product Segment, Through 2023
    • Table 47: Indian Market for Needle-free Devices, by Product Segment, Through 2023
    • Table 48: Japanese Market for Needle-free Devices, by Product Segment, Through 2023
    • Table 49: South Korean Market for Needle-free Devices, by Product Segment, Through 2023
    • Table 50: Rest of Asia-Pacific Market for Needle-free Devices, by Product Segment, Through 2023
    • Table 51: South American Market for Needle-free Devices, by Product Segment, Through 2023
    • Table 52: HIV Acquisition in the Middle East and North Africa, by Mode, 2014
    • Table 53: Middle Eastern and African Market for Needle-free Devices, by Product Segment, Through 2023
    • Table 54: Key Metered Dose Inhalers in the Market
    • Table 55: Transdermal Patches: Key Marketed Products
    • Table 56: Other Novel Technologies: Marketed Products
    • Table 57: Key Metered Dose Inhalers: Pipeline Products
    • Table 58: Transdermal Patches: Pipeline Products
    • Table 59: Differences in Regulatory Approvals in the United States and Europe
    • Table 60: 3M: Net Revenue, 2015-2017
    • Table 61: 3M: Marketed Products, 2017
    • Table 62: Akra Dermojet Brand Products: Marketed Products, 2017
    • Table 63: Antares Pharma, Inc.: Marketed Products, 2017
    • Table 64: Aradigm Corp.: Marketed Products, 2017
    • Table 65: AstraZeneca Plc: Net Revenue, 2015-2017
    • Table 66: Medtronic: Net Revenue, 2015-2017
    • Table 67: Novartis: Net Revenue, 2017
    • Table 68: Teva Pharmaceuticals Industries Ltd.: Net Revenue, 2015-2017
    • Table 69: Abbreviations Used in Needle-free Devices and Technologies

List of Figures

  • Summary Figure: Global Market for Needle-free Devices, by Product Type, 2017-2023
    • Figure 1: Diabetes Prevalence, by Region, 2015
    • Figure 2: Global Market for Needle-free Devices, by Product Type, 2017-2023
    • Figure 3: Global Market for Needle-free Injectors, by Region, 2017-2023
    • Figure 4: Global Market for Needle-free Injectors, by Medication, 2017-2023
    • Figure 5: Global Market for Needle-free Injectors, by Drug Delivery, 2017-2023
    • Figure 6: Global Market for Inhaler Technologies, by Region, 2017-2023
    • Figure 7: Global Market for Inhaler Technologies, by Type, 2017-2023
    • Figure 8: Global Market for Transdermal Patch Technologies, by Region, 2017-2023
    • Figure 9: Global Market for Other Novel Technologies, by Region, 2017-2023
    • Figure 10: Global Market Share for Needle-free Devices, by Application, 2017
    • Figure 11: Global Market for Needle-free Devices, by Region, 2017-2023
    • Figure 12: Prevalence of Diabetes in North America, by Country, 2017
    • Figure 13: United States Market for Needle-free Devices, by Product Segment, 2017-2023
    • Figure 14: Canadian Market for Needle-free Devices, by Product Segment, 2017-2023
    • Figure 15: Mexican Market for Needle-free Devices, by Product Segment, 2017-2023
    • Figure 16: Prevalence of Diabetes in Europe, by Country, 2017
    • Figure 17: European Market for Needle-free Devices, by Product Segment, 2017-2023
    • Figure 18: German Market for Needle-free Devices, by Product Segment, 2017-2023
    • Figure 19: U.K. Market for Needle-free Devices, by Product Segment, 2017-2023
    • Figure 20: French Market for Needle-free Devices, by Product Segment, 2017-2023
    • Figure 21: Italian Market for Needle-free Devices, by Product Segment, 2017-2023
    • Figure 22: Spanish Market for Needle-free Devices, by Product Segment, 2017-2023
    • Figure 23: Prevalence of Diabetes in Asia-Pacific, by Country, 2017
    • Figure 24: Asia-Pacific Market for Needle-free Devices, by Product Segment, 2017-2023
    • Figure 25: Chinese Market for Needle-free Devices, by Product Segment, 2017-2023
    • Figure 26: Indian Market for Needle-free Devices, by Product Segment, 2017-2023
    • Figure 27: Japanese Market for Needle-free Devices, by Product Segment, 2017-2023
    • Figure 28: South Korean Market for Needle-free Devices, by Product Segment, 2017-2023
    • Figure 29: Rest of Asia-Pacific Market for Needle-free Devices, by Product Segment, 2017-2023
    • Figure 30: South American Market for Needle-free Devices, by Product Segment, 2017-2023
    • Figure 31: Middle Eastern and African Market for Needle-free Devices, by Product Segment, 2017-2023
    • Figure 32: Diabetes Prevalence in Africa, 2017
    • Figure 33: Diabetes Prevalence in Middle East and Pakistan, 2017
    • Figure 34: Diabetes Prevalence in South and Central America, 2017
    • Figure 35: Diabetes Prevalence in South-East Asia, 2017
    • Figure 36: Diabetes Prevalence in North America and Caribbean, 2017
    • Figure 37: Diabetes Prevalence in Europe, 2017
    • Figure 38: 3M: Net Revenue, by Healthcare Segment, 2015-2017